Mining cancer genomes for change-of-metabolic-function mutations
Open Access
- 10 November 2023
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-11
Abstract
Enzymes with novel functions are needed to enable new organic synthesis techniques. Drawing inspiration from gain-of-function cancer mutations that functionally alter proteins and affect cellular metabolism, we developed METIS (Mutated Enzymes from Tumors In silicoScreen). METIS identifies metabolism-altering cancer mutations using mutation recurrence rates and protein structure. We used METIS to screen 298,517 cancer mutations and identify 48 candidate mutations, including those previously identified to alter enzymatic function. Unbiased metabolomic profiling of cells exogenously expressing a candidate mutant (OGDHLp.A400T) supports an altered phenotype that boosts in vitro production of xanthosine, a pharmacologically useful chemical that is currently produced using unsustainable, water-intensive methods. We then applied METIS to 49 million cancer mutations, yielding a refined set of candidates that may impart novel enzymatic functions or contribute to tumor progression. Thus, METIS can be used to identify and catalog potentially-useful cancer mutations for green chemistry and therapeutic applications.Keywords
This publication has 41 references indexed in Scilit:
- Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov ModelsHuman Mutation, 2012
- Enzyme redesign guided by cancer-derived IDH1 mutationsNature Chemical Biology, 2012
- Predicting the functional impact of protein mutations: application to cancer genomicsNucleic Acids Research, 2011
- 2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase MutationsPLOS ONE, 2011
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeProceedings of the National Academy of Sciences, 2011
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Opportunities in metabolic engineering to facilitate scalable alkaloid productionNature Chemical Biology, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004